Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - TOTAL CURRENT ASSETS
Total Current Assets OCUL - Ocular Therapeutix, Inc.
232 M
LAST VALUE
10.18%
2 YEAR CAGR
32.82%
5 YEAR CAGR
29.13%
10 YEAR CAGR